Report Overview
Report Overview
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection. The oral vaccine market is driven by the growing demand for convenient and needle-free vaccination options, especially in pediatric and developing regions. Oral vaccines offer advantages like ease of administration, increased patient compliance, and simplified logistics, making them suitable for mass vaccination programs and reaching remote areas with limited healthcare infrastructure. The potential for improved vaccine stability and reduced production costs further contribute to market growth. However, the market also faces challenges, such as the need for enhanced vaccine stability to withstand gastrointestinal conditions and ensuring consistent efficacy across diverse populations. Additionally, regulatory complexities and the requirement for stringent safety and efficacy data can pose obstacles for oral vaccine manufacturers. To succeed in this market, companies must focus on innovative vaccine delivery technologies, conduct robust clinical trials, collaborate with global health agencies, and address public perception and trust in oral vaccine safety and effectiveness.
The global Orally Administered Vaccine market size was estimated at USD 2828.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Orally Administered Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Orally Administered Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Orally Administered Vaccine market.
Global Orally Administered Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Orally Administered Vaccine Market
Overview of the regional outlook of the Orally Administered Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orally Administered Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Orally Administered Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
- 1.2 Key Market Segments
- 1.2.1 Orally Administered Vaccine Segment by Type
- 1.2.2 Orally Administered Vaccine Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Orally Administered Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Orally Administered Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Orally Administered Vaccine Product Life Cycle
- 3.3 Global Orally Administered Vaccine Sales by Manufacturers (2020-2025)
- 3.4 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Orally Administered Vaccine Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Orally Administered Vaccine Market Competitive Situation and Trends
- 3.8.1 Orally Administered Vaccine Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Orally Administered Vaccine Industry Chain Analysis
- 4.1 Orally Administered Vaccine Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Orally Administered Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Orally Administered Vaccine Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Orally Administered Vaccine Market
- 5.7 ESG Ratings of Leading Companies
- 6 Orally Administered Vaccine Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Orally Administered Vaccine Sales Market Share by Type (2020-2025)
- 6.3 Global Orally Administered Vaccine Market Size by Type (2020-2025)
- 6.4 Global Orally Administered Vaccine Price by Type (2020-2025)
- 7 Orally Administered Vaccine Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Orally Administered Vaccine Market Sales by Application (2020-2025)
- 7.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2020-2025)
- 7.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2020-2025)
- 8 Orally Administered Vaccine Market Sales by Region
- 8.1 Global Orally Administered Vaccine Sales by Region
- 8.1.1 Global Orally Administered Vaccine Sales by Region
- 8.1.2 Global Orally Administered Vaccine Sales Market Share by Region
- 8.2 Global Orally Administered Vaccine Market Size by Region
- 8.2.1 Global Orally Administered Vaccine Market Size by Region
- 8.2.2 Global Orally Administered Vaccine Market Size by Region
- 8.3 North America
- 8.3.1 North America Orally Administered Vaccine Sales by Country
- 8.3.2 North America Orally Administered Vaccine Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Orally Administered Vaccine Sales by Country
- 8.4.2 Europe Orally Administered Vaccine Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Orally Administered Vaccine Sales by Region
- 8.5.2 Asia Pacific Orally Administered Vaccine Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Orally Administered Vaccine Sales by Country
- 8.6.2 South America Orally Administered Vaccine Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Orally Administered Vaccine Sales by Region
- 8.7.2 Middle East and Africa Orally Administered Vaccine Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Orally Administered Vaccine Sales by Region
- 9 Orally Administered Vaccine Market Production by Region
- 9.1 Global Production of Orally Administered Vaccine by Region(2020-2025)
- 9.2 Global Orally Administered Vaccine Revenue Market Share by Region (2020-2025)
- 9.3 Global Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Orally Administered Vaccine Production
- 9.4.1 North America Orally Administered Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Orally Administered Vaccine Production
- 9.5.1 Europe Orally Administered Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Orally Administered Vaccine Production (2020-2025)
- 9.6.1 Japan Orally Administered Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Orally Administered Vaccine Production (2020-2025)
- 9.7.1 China Orally Administered Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Merck
- 10.1.1 Merck Basic Information
- 10.1.2 Merck Orally Administered Vaccine Product Overview
- 10.1.3 Merck Orally Administered Vaccine Product Market Performance
- 10.1.4 Merck Business Overview
- 10.1.5 Merck SWOT Analysis
- 10.1.6 Merck Recent Developments
- 10.2 GSK
- 10.2.1 GSK Basic Information
- 10.2.2 GSK Orally Administered Vaccine Product Overview
- 10.2.3 GSK Orally Administered Vaccine Product Market Performance
- 10.2.4 GSK Business Overview
- 10.2.5 GSK SWOT Analysis
- 10.2.6 GSK Recent Developments
- 10.3 Sanofi
- 10.3.1 Sanofi Basic Information
- 10.3.2 Sanofi Orally Administered Vaccine Product Overview
- 10.3.3 Sanofi Orally Administered Vaccine Product Market Performance
- 10.3.4 Sanofi Business Overview
- 10.3.5 Sanofi SWOT Analysis
- 10.3.6 Sanofi Recent Developments
- 10.4 Lanzhou Institute
- 10.4.1 Lanzhou Institute Basic Information
- 10.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
- 10.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
- 10.4.4 Lanzhou Institute Business Overview
- 10.4.5 Lanzhou Institute Recent Developments
- 10.5 Serum Institute
- 10.5.1 Serum Institute Basic Information
- 10.5.2 Serum Institute Orally Administered Vaccine Product Overview
- 10.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
- 10.5.4 Serum Institute Business Overview
- 10.5.5 Serum Institute Recent Developments
- 10.6 Valneva
- 10.6.1 Valneva Basic Information
- 10.6.2 Valneva Orally Administered Vaccine Product Overview
- 10.6.3 Valneva Orally Administered Vaccine Product Market Performance
- 10.6.4 Valneva Business Overview
- 10.6.5 Valneva Recent Developments
- 10.7 Shanghai United Cell
- 10.7.1 Shanghai United Cell Basic Information
- 10.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
- 10.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
- 10.7.4 Shanghai United Cell Business Overview
- 10.7.5 Shanghai United Cell Recent Developments
- 10.8 Bibcol
- 10.8.1 Bibcol Basic Information
- 10.8.2 Bibcol Orally Administered Vaccine Product Overview
- 10.8.3 Bibcol Orally Administered Vaccine Product Market Performance
- 10.8.4 Bibcol Business Overview
- 10.8.5 Bibcol Recent Developments
- 10.9 PaxVax
- 10.9.1 PaxVax Basic Information
- 10.9.2 PaxVax Orally Administered Vaccine Product Overview
- 10.9.3 PaxVax Orally Administered Vaccine Product Market Performance
- 10.9.4 PaxVax Business Overview
- 10.9.5 PaxVax Recent Developments
- 10.10 Vabiotech
- 10.10.1 Vabiotech Basic Information
- 10.10.2 Vabiotech Orally Administered Vaccine Product Overview
- 10.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
- 10.10.4 Vabiotech Business Overview
- 10.10.5 Vabiotech Recent Developments
- 10.11 Tiantan Biological
- 10.11.1 Tiantan Biological Basic Information
- 10.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
- 10.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
- 10.11.4 Tiantan Biological Business Overview
- 10.11.5 Tiantan Biological Recent Developments
- 10.12 EuBiologics
- 10.12.1 EuBiologics Basic Information
- 10.12.2 EuBiologics Orally Administered Vaccine Product Overview
- 10.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
- 10.12.4 EuBiologics Business Overview
- 10.12.5 EuBiologics Recent Developments
- 10.13 Panacea Biotec Ltd
- 10.13.1 Panacea Biotec Ltd Basic Information
- 10.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
- 10.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
- 10.13.4 Panacea Biotec Ltd Business Overview
- 10.13.5 Panacea Biotec Ltd Recent Developments
- 10.14 Bio-Med
- 10.14.1 Bio-Med Basic Information
- 10.14.2 Bio-Med Orally Administered Vaccine Product Overview
- 10.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
- 10.14.4 Bio-Med Business Overview
- 10.14.5 Bio-Med Recent Developments
- 10.15 Halfkin Bio-Pharmaceuticals
- 10.15.1 Halfkin Bio-Pharmaceuticals Basic Information
- 10.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
- 10.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
- 10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
- 10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
- 10.1 Merck
- 11 Orally Administered Vaccine Market Forecast by Region
- 11.1 Global Orally Administered Vaccine Market Size Forecast
- 11.2 Global Orally Administered Vaccine Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Orally Administered Vaccine Market Size Forecast by Country
- 11.2.3 Asia Pacific Orally Administered Vaccine Market Size Forecast by Region
- 11.2.4 South America Orally Administered Vaccine Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Orally Administered Vaccine by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Orally Administered Vaccine Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Orally Administered Vaccine by Type (2026-2035)
- 12.1.2 Global Orally Administered Vaccine Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Orally Administered Vaccine by Type (2026-2035)
- 12.2 Global Orally Administered Vaccine Market Forecast by Application (2026-2035)
- 12.2.1 Global Orally Administered Vaccine Sales (K MT) Forecast by Application
- 12.2.2 Global Orally Administered Vaccine Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Orally Administered Vaccine Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings